HIVandItsTreatment Cbrochure en
HIVandItsTreatment Cbrochure en
HIVandItsTreatment Cbrochure en
Fact Sheets
P.O. Box 6303, Rockville, MD 20849-6303 Telephone: 1-800-448-0440 International: 301-519-0459 Fax: 301-519-6616 TTY/TTD: 888-480-3739 Live Help: https://webcontact.aspensys.com/AidsInfo/intro.jsp E-mail: ContactUs@aidsinfo.nih.gov Web: http://aidsinfo.nih.gov
Table of Contents
Testing HIV Positive Do I Have AIDS? Seeing an HIV Doctor Starting Anti-HIV Medications Recommended HIV Treatment Regimens Approved Medications to Treat HIV Infection Is My Treatment Regimen Working? HIV Treatment Regimen Failure Changing My HIV Treatment Regimen What is Treatment Adherence? Adhering To My HIV Treatment Regimen HIV and Pregnancy Understanding HIV Prevention
This information is based on the U.S. Department of Health and Human Services' Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents (available at http://aidsinfo.nih.gov).
What is AIDS?
AIDS is the most serious stage of HIV infection. It results from the destruction of the infected person's immune system. Your immune system is your body's defense system. Cells of your immune system fight off infection and other diseases. If your immune system does not work well, you are at risk for serious and life-threatening infections and cancers. HIV attacks and destroys the disease-fighting cells of the immune system, leaving the body with a weakened defense against infections and cancer.
CDC. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR 1992;41(no. RR-17).
Reviewed Sept. 2005
This information is based on the U.S. Department of Health and Human Services' Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents (available at http://aidsinfo.nih.gov).
To ensure accurate results, viral load testing should be done at two different times, by the same laboratory, using the same type of test. The results of different types of tests may differ. Your doctor may also order: Complete blood count Blood chemistry profile (including liver function tests) Tests for other sexually transmitted diseases (STDs) Tests for other infections, such as hepatitis, tuberculosis, or toxoplasmosis
If my doctor and I decide to delay treatment, will I need to have my CD4 count and viral load tested again?
Yes. HIV infected people who have not started drug therapy should have a viral load test every 3 to 4 months and a CD4 count every 3 to 6 months. You and your doctor will use the test results to monitor your infection and to decide when to start treatment.
This information is based on the U.S. Department of Health and Human Services' Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents (available at http://aidsinfo.nih.gov).
If anti-HIV medications can help me stay healthy, why wait to start treatment?
Once you begin treatment, you may need to continue taking anti-HIV medications for the rest of your life. Although newer anti-HIV medications are easier to take, starting treatment usually means a significant adjustment in your lifestyle. Some anti-HIV medications need to be taken several times a day at specific times and may require a change in meals and mealtimes. In addition to their desired effects, anti-HIV medications may have negative side effects, some of which are serious. If the virus is not suppressed completely, drug resistance can develop. Side effects and drug resistance may limit your future treatment options.
This information is based on the U.S. Department of Health and Human Services' Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents (available at http://aidsinfo.nih.gov).
In general, taking only one or two drugs is not recommended because any decrease in viral load is almost always temporary without three or more drugs. The exception is the recommendation for pregnant women, who may take Retrovir alone or with other drugs to reduce the risk of passing HIV to their infants. If you are pregnant or considering becoming pregnant, there are additional treatment considerations. HIV and Pregnancy Fact Sheet has more information on HIV treatment and pregnancy.
This information is based on the U.S. Department of Health and Human Services' Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents (available at http://aidsinfo.nih.gov).
Class
Generic Name
Manufacturer
1. Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) NNRTIs bind to and disable reverse transcriptase, a protein that HIV needs to make more copies of itself. Delavirdine Efavirenz Nevirapine Rescriptor, DLV Sustiva, EFV Viramune, NVP Pfizer Bristol-Myers Squibb Boehringer Ingelheim
April 4, 1997 Sept. 17, 1998 June 21, 1996
2. Nucleoside Reverse Transcriptase Inhibitors (NRTIs) NRTIs are faulty versions of building blocks that HIV needs to make more copies of itself. When HIV uses an NRTI instead of a normal building block, reproduction of the virus is stalled. Abacavir Abacavir, Lamivudine Abacavir, Lamivudine, Zidovudine Didanosine Emtricitabine Emtricitabine, Tenofovir DF Lamivudine Lamivudine, Zidovudine Stavudine Tenofovir DF Zalcitabine Zidovudine Ziagen, ABC Epzicom Trizivir GlaxoSmithKline GlaxoSmithKline GlaxoSmithKline
Dec. 17, 1998 Aug. 2, 2004 Nov. 14, 2000
Videx, ddI, Videx EC Emtriva, FTC, Coviracil Truvada Epivir, 3TC Combivir Zerit, d4T Viread, TDF Hivid, ddC Retrovir, AZT, ZDV
Bristol-Myers Squibb Gilead Sciences Gilead Sciences GlaxoSmithKline GlaxoSmithKline Bristol-Myers Squibb Gilead Sciences Hoffmann-La Roche GlaxoSmithKline
Oct. 9, 1991 Oct. 31, 2000 (EC) July 2, 2003 Aug. 2, 2004 Nov. 17, 1995 Sept. 27, 1997 June 24, 1994 Oct. 26, 2001 June 19, 1992 March 19, 1987
Page 1 of 2 Reviewed Sept. 2005
This information is based on the U.S. Food and Drug Administration's Drugs Used in the Treatment of HIV Infection (available at: http://www.fda.gov/oashi/aids/virals.html).
Generic Name
Manufacturer
Viracept, NFV
Agouron Pharmaceuticals
Ritonavir Saquinavir
Tipranavir 4. Fusion Inhibitors Fusion inhibitors work by blocking HIV entry into cells. Enfuvirtide
Aptivus, TPV
Boehringer Ingelheim
Fuzeon, T-20
This information is based on the U.S. Food and Drug Administration's Drugs Used in the Treatment of HIV Infection (available at: http://www.fda.gov/oashi/aids/virals.html).
every 3 to 6 months throughout your treatment. HIV treatment should increase your CD4 count or at least keep it from going down. Talk to your health care provider if you are concerned about your CD4 counts.
This information is based on the U.S. Department of Health and Human Services' Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents (available at http://aidsinfo.nih.gov).
What happens if my regimen fails? What are the three types of regimen failure?
1. Virologic failure: Regimens should lower the amount of HIV in your blood to undetectable levels. Virologic failure has occurred if HIV can still be detected in your blood 48 weeks after starting treatment, or if it is detected again after treatment had previously lowered your viral load to undetectable. 2. Immunologic failure: An effective regimen should increase the number of CD4 cells in your blood or at least prevent the number from going down. Immunologic failure has occurred if your CD4 count decreases below a baseline measurement or does not increase above the baseline count within your first year of therapy. 3. Clinical failure: Clinical failure has occurred if you experience an HIV-related infection or a decline in physical health despite at least 3 months of anti-HIV treatment. Virologic failure is the most common kind of regimen failure. People with virologic failure who do not switch to a more effective drug regimen usually progress to immunologic failure within about 3 years. Immunologic failure may be followed by clinical failure.
This information is based on the U.S. Department of Health and Human Services' Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents (available at http://aidsinfo.nih.gov).
If your treatment regimen fails, your doctor will evaluate your treatment history, medication side effects, problems you may have had with taking the medications as directed, your physical condition, and results of drug resistance testing to determine why your regimen is failing. You and your doctor may then select a new drug regimen to better control your infection. See Changing Regimens Fact Sheet for more information about changing treatment regimens.
Changing Regimens
If your regimen is failing and you and your doctor have ruled out adherence, tolerability, and medication interactions, you should consider changing your regimen. Before changing anti-HIV medications, talk with your doctor about: anti-HIV medications you have taken before the strength of the new medications your doctor recommends possible side effects of the new medications how well you will be able to adhere to the new regimen the number of anti-HIV medications that you have not yet used Your doctor will confirm that your regimen is failing with at least two viral load tests and three CD4 counts. You should also be tested for drug resistance while you are taking the failing regimen. In general, your new treatment regimen should include three or more medications. You and your doctor will choose the medications based on your medication history, results of resistance testing, and medication side effects. If you have already taken many of the FDA-approved anti-HIV medications, your doctor may recommend a new medication under investigation. You may be eligible to participate in a clinical trial using new drugs or treatment strategies. For more information about participating in a clinical trial, ask your doctor, or visit the "Clinical Trials" section of the AIDSinfo Web site at: http:// aidsinfo.nih.gov/ClinicalTrials/.
What is adherence?
Adherence refers to how closely you follow (adhere to) your treatment regimen. If your regimen is failing because you cannot adhere to it, you and your doctor should discuss why you are having difficulty taking your medication and what you can do to improve your adherence. Your doctor may change your regimen to reduce the number of pills you take or how often you take them. For more information about adherence, see Adherence and Adhering to a Regimen Fact Sheets.
What is tolerability?
Tolerability refers to how many and what types of negative medication side effects you experience. If the side effects are severe, you may need to change your regimen. Your doctor will ask you what side effects you have and how long you have had them. You and your doctor will decide whether to treat the side effects or to change your anti-HIV medications.
This information is based on the U.S. Department of Health and Human Services' Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents (available at http://aidsinfo.nih.gov).
Sleeping through doses Traveling away from home Being too busy Feeling sick or depressed Forgetting to take medications
Your travel, sleep, and eating schedule Possible side effects of medication Other medications you are taking and their possible
interaction with anti-HIV medications
This information is based on the U.S. Department of Health and Human Services' Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents (available at http://aidsinfo.nih.gov).
Talk with your doctor about your treatment regimen. Get a written copy of your treatment plan that lists
each medication, when and how much to take, and if it must be taken with food or on an empty stomach. Understand how important adherence is (see Adherence Fact Sheet). Be honest about personal issues that may affect your adherence. Adherence may be harder for people dealing with substance abuse or alcoholism, unstable housing, mental illness, or other life challenges. Consider a "dry run." Practice your treatment regimen using vitamins, jelly beans, or mints. This will help you determine ahead of time which doses might be difficult to take correctly. Develop a plan that works for you.
Many people find it helpful to identify the activities they normally do at the times they will be taking their medication. People who arrange their medication schedule around their daily routines adhere to their treatment plans better than those who do not.
This information is based on the U.S. Department of Health and Human Services' Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents (available at http://aidsinfo.nih.gov).
This information is based on the U.S. Public Health Service's Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV-1 Transmission in the United States (available at http://aidsinfo.nih.gov).
I am taking anti-HIV medications and my viral load is undetectable. Am I cured? Can I infect others?
An undetectable viral load does not mean that you are cured. It means that the amount of HIV virus in your blood is so low that the viral load tests cannot detect it. You are still infected with HIV and can infect others. You should continue to use prevention strategies and should see your health care provider regularly.
Always use prevention strategies, such as condoms and safer sex practices. If you inject drugs, don't share your works with anyone else. Talk with your health care provider if you have trouble sticking to these prevention strategies. You and your provider can then find ways to make your high-risk behaviors safer.
This information is based on the U.S. Department of Health and Human Services' Incorporating HIV Prevention into the Medical Care of Persons Living with HIV (available at http://aidsinfo.nih.gov).